Epoxomicin (Proteasome inhibitor) - 5mG.

Epoxomicin – 5 mg: is a highly selective and potent proteasome inhibitor widely used in cellular and molecular research. It irreversibly binds to the 20S proteasome, effectively blocking proteasomal protein degradation. This makes it an essential tool for studying ubiquitin-proteasome pathway, protein turnover, and apoptosis mechanisms in various cell types.

Epoxomicin is commonly used in proteasome activity assays, apoptosis studies, cancer research, and neurodegenerative disease research, offering reliable inhibition of proteasomal activity with high specificity.